Approximately 60 Principal Investigators, and several Post Docs, both basic science/laboratory and clinical researchers, work within the Research Institute and the Medical Center.
California Pacific Medical Center physicians from many different disciplines engage in active research. Take a look at our Clinical Trials section for some of these projects.
Arshia Sadreddin, M.D.: Pioneering new approaches to the treatment of Parkinson’s disease and movement disorders
In 2014, California Pacific Medical Center (CPMC) and its Research Institute (CPMCRI) welcomed Arshia Sadreddin, M.D., who leads the hospital’s new movement disorders program. Dr. Sadreddin was Assistant Professor of Neurology, previously appointed as physician and Director of the Hyperkinetic Movement Disorders and Huntington's Disease Program at the prestigious Barrow Neurological Institute/Muhammad Ali Parkinson Center at St. Joseph's Hospital & Medical Center in Phoenix.
A renowned neurologist, Dr. Sadreddin specializes in medical and surgical treatments of movement disorders. She is one of the few neurologists in the U.S. with special training and expertise in deep brain stimulation for the treatment of Parkinson's disease, as well as essential tremor, and dystonia. She conducts research studies in Parkinson’s disease (assessing motor and non-motor functions), Huntington’s disease, and dystonia, and has experience as a Principal Investigator on numerous national, multicenter clinical trials evaluating the efficacy and safety of new treatments for these nervous system disorders.
“We are thrilled to have Dr. Sadreddin join our neuroscience team and anticipate her presence as Medical Director of Movement Disorders will result in significant increases in clinical research and clinical trial activity for movement disorders among the hospital’s already active neuroscience research portfolio,” said Peter Weber, M.D., CPMCRI Scientist, and Surgical Director of the Sutter Pacific Epilepsy Program.
Collaborating with other Sutter Health movement disorders specialists including Matthew Arnold, M.D., and Nicklesh Thakur, M.D., Dr. Sadreddin will lead investigator-initiated and industry-sponsored clinical trials investigating new approaches to the treatment of Parkinson’s disease and other movement disorders.
“This is an exciting time in movement disorders research,” said Dr. Sadreddin. “With advances in new technologies, surgical and pharmacologic therapies and our expanding knowledge of disease mechanisms, we can focus our efforts on bringing novel treatments to patients to improve their symptoms and quality of life. I am thrilled to collaborate among the renowned expertise of Sutter Health’s leaders in this area to help further these discoveries.”
With support from CPMC’s Women’s Board and donors, next year Dr. Sadreddin will champion a Parkinson’s disease resource center at the hospital to provide a full range of care services including educational and support materials, classes, and various activities for patients and their caregivers.
Dr. Sadreddin began her medical training at Ross University School of Medicine in Dominica, West Indies, and completed her clinical clerkships at a UCLA-affiliated hospital. This was followed by residency training in neurology and a fellowship in movement disorders and deep brain stimulation at the world-renowned Barrow Neurological Institute/Muhammad Ali Parkinson Center in Phoenix, Arizona.
- Peggy Cawthon, PhD, MPH
- Stewart Cooper, MD
- Steven Cummings, MD
- Shanaz Dairkee, PhD
- Robert Debs, MD
- Pierre Desprez, PhD
- Dan Evans, PhD
- Gantt Galloway, PharmD
- Mohammed Kashani-Sabet, MD
- Sean D. McAllister, PhD
- John Mendelson, MD
- John Muschler, PhD
- Michael C. Rowbotham, MD
- Liliana Soroceanu, MD, PhD
- Katie Stone, PhD
- Gregory James Tranah, PhD
- Cassandra Vieten, PhD
- Esther Wei, ScD
- Li Xi Yang, MD, PhD
- Garret L. Yount, PhD